A insane promise to buy services rendered at market price

REVERSE VOXSPLAINING: DRUGS VS. CHAIRS

 EpiPens, useful medical devices which reverse potentially fatal allergic reactions, have recently quadrupled in price, putting pressure on allergy sufferers and those who care for them. Vox writes that this “tells us a lot about what’s wrong with American health care” – namely that we don’t regulate it enough:

The story of Mylan’s giant EpiPen price increase is, more fundamentally, a story about America’s unique drug pricing policies. We are the only developed nation that lets drugmakers set their own prices, maximizing profits the same way sellers of chairs, mugs, shoes, or any other manufactured goods would.

Common misconception about the string pushers who claim exceptions for medical.

But we are stuck, for quite some time with the problem of Congress and Pharma, and it is more than the patent issues as this case.  This is not a problem that is going away in one step of reform, and we need, not me, but a smart senator who focuses on this problem, managing drug prices when no alternate exists, deals with the patent issues, and watches the total drug bill. A goto senator on this topic, someone who wanders the production line.

The state capitals can deliver these senator pros,but they won't do it without cash payments. How hard will it be to educate the town of Burlington Vermont on the problem? Half the city budget would depend on 5,000 senior members knowing the issue, most of them reachable via google search. They will send us a senator more astute than Bernie.